a manufacturing capability recognized by global standards
FHL Aesthetics focuses on developing regenerative cosmeceutical products using safe and efficacious bioabsorbable materials like hyaluronic acid, polynucleotides.
With a patent issued for a long-lasting hyaluronic acid gel composition, our products maximize safety with technology that results in zero BDDE. Our products provides various treatments options resulting in enhanced customer saftisfaction.
FHL’s proprietary DIAMOLD technique marrying “Dialysis” and “Molding”, highlights the critical steps of cross-linking, dialysis, and chopping which in combination represent the processes that determine the superior characteristics of FHL’s HA filler.
By using polymer hyaluronic acid, FHL achieves higher product safety levels by minimizing the use of cross-linking agents. DIAMOLD was developed by FHL with two intentions: to remove impurities and cross-linking agents, and minimize excessive post-injection swelling.
FHL’s proprietary HYLO® Hybrid Technology is designed to support and secure space for high-molecular-weight hyaluronic acid (H-HA) and promote the physiological activity of low-molecular-weight hyaluronic acid (L-HA).
This technology uses polymer chains of various lengths to create stronger bonds of hybrid complexes and is a complementary technology employing the physical advantages of H-HA and the size and physiological characteristics of L-HA.